Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves generic version of Diamox

June 6, 1997

Oculex and Storz sign marketing agreement for ocular product

June 5, 1997

Didronel PMO approved for prevention of osteoporosis in U.K.

June 5, 1997

New i.v. formulation of amiodarone better tolerated in patients

June 2, 1997

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

June 2, 1997

DuPont Merck receives FDA approval for nuclear imaging breast cancer test

May 30, 1997

U.K. introduction for Nasonex

May 29, 1997

Promising data from pivotal trials of Actiq reported at ASCO

May 26, 1997

Mylan receives FDA approval of generic captopril/hydrochlorothiazide

May 23, 1997

Mylan receives FDA approval for generic etodolac

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.